Closure of an Open Wound Associated with Bisphosphonate-Related Osteonecrosis of the Jaw in a Breast Cancer Patient

Soolari, Nafiseh; Soolari, Ahmad
January 2011
Open Dentistry Journal;2011, Vol. 5, p163
Academic Journal
Background and Objective: Many clinicians will not treat patients presenting with bisphosphonate-related osteonecrosis of the jaw following long-term use of bisphosphonates because of the lack of predictable outcomes. Materical and Methods: The patient presented with pain from a nonhealing lesion in the posterior maxilla following extraction of the maxillary right third molar. The lesion had not responded to any conventional dental treatment. The patient had suffered from breast cancer, and her treatment included several years of therapy with Zometa (zoledronic acid), a bisphosphonate. Results: The patient stopped taking Zometa and commenced rinsing with phosphate buffer-stabilized 0.1% chlorine dioxide-containing mouthwash. After 5 months, changes in the morphology of the lesion were noted and the soft tissue had closed over the open wound. Conclusion: Cessation of bisphosphonate therapy and usage of a phosphate buffer-stabilized 0.1% chlorine dioxide-containing mouthwash lessened the patient's pain and resulted in closure of the soft tissue lesion.


Related Articles

  • Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. Sedghizadeh, Parish P.; Kumar, Satish K. S.; Gorur, Amita; Schaudinn, Christoph; Shuler, Charles F.; Costerton, J. William // Journal of the American Dental Association (JADA);Oct2009, Vol. 140 Issue 10, p1259 

    The article presents a study which examined the use of microbial biofilms in osteomyelitis of the jaw (OMJ) and osteonecrosis of the jaw (ONJ), and analyzed the potential of a biofilm-mediated infectious disease in ONJ secondary to bisphosphonate therapy. The results of the study were based on...

  • Osteonecrosis of the jaw associated with antiresorptives: more evidence on the role of infection. Pazianas, Michael // IBMS BoneKEy;Nov2013, Vol. 10 Issue 11, p441 

    The author comments on the study conducted by S. Kalyan and colleagues which examines the role of infection in the initiation of osteonecrosis of the jaw (ONJ) associated with antiresorptives. He says that the significance of this study on the unaffected part of monocytes in patients treated...

  • Ostéonécrose des maxillaires : quand l'ancien traitement avec bisphosphonates est méconnu. Renoux, Marion; Folliguet, Marysette; Nguyen, Thông; Radoï, Loredana // Médecine Buccale Chirurgie Buccale;2014, Vol. 20 Issue 3, p177 

    Introduction: Older people have multiple morbidities and are polymedicated. The medicines are prescribed by several doctors who are unaware of each other, hence the increased risk of adverse effects. Observation: We report the case of an institutionalized 91-year-old female patient. Following a...

  • Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment. GÓMEZ-MORENO, G.; ARRIBAS-FERNÁNDEZ, M. C.; FERNÁNDEZ-GUERRERO, M.; BOQUETE-CASTRO, A.; AGUILAR-SALVATIERRA, A.; GUARDIA, J.; BOTTICELLI, D.; CALVO-GUIRADO, J. L. // European Review for Medical & Pharmacological Sciences;May2014, Vol. 18 Issue 9, p1391 

    Bisphosphonates are a type of drugs known to inhibit bone resorption through complex interventions.Their primary mechanism of action is aimed at the cellular level, inhibiting osteoclast activity and, thus, bone resorption. Bisphosphonates are, therefore, very widely used, with many patients...

  • Bisphosphonate-Related Osteonecrosis of the Jaws: a real Challenge for Dentists. Ioana-Auriţa, Albu; Cecilia, Petrovan; Mariana, Păcurar; Albu, DE; Csinszka, K.-Ivacson A; Golu, VM; Copotoiu, C // Acta Medica Marisiensis;Jun2015, Vol. 61 Issue 2, p115 

    Background: Osteonecrosis of the jaw is a serious complication associated with oral and intravenous bisphosphonate therapy. Its pathogenesis is not well understood and its management is difficult. The aim of ourstudy was to evaluate the awareness of dentists in Târgu Mureş on the...

  • Osteonecrosis of the jaw. Ian Reid; Tim Cundy // Skeletal Radiology;Jan2009, Vol. 38 Issue 1, p5 

    Abstract  Osteonecrosis of the jaw (ONJ) was first reported in the dental literature in 2003. The term was coined to describe a spectrum of dental problems seen in cancer patients treated with high doses of intravenous bisphosphonates for the prevention of skeletal-related events. By...

  • Bisphosphonates.  // Reactions Weekly;3/26/2011, Issue 1344, p10 

    The article describes the cases of two men and 25 women aged 62 to 85 years who developed osteonecrosis of the jaw (ONJ) while receiving biphosphonates, including alendronic acid, ibandronic acid and pamidronic acid.

  • Bisphosphonates.  // Reactions Weekly;03/23/2013, Issue 1445, p12 

    The article presents a case study of the development of osteonecrosis of the jaw in four men and sixteen women, aged 48-84 years while receiving bisphosphonates.

  • Zoledronic acid.  // Reactions Weekly;4/24/2010, Issue 1298, p31 

    The article describes the case of a 47-year-old man who developed osteonecrosis of the jaw (ONJ) while receiving zoledronic acid.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics